Who is sponsoring NCT04241770?

NCT04241770 is sponsored by Turkish Society of Cardiology.

What drugs are being tested in NCT04241770?

Interventions in NCT04241770: no intervention.

What condition does NCT04241770 study?

NCT04241770 studies Acute Myocardial Infarction.

Is NCT04241770 still recruiting?

NCT04241770 is currently status unknown. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04241770: TURKMI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TURKish Acute Myocardial Infarction Registry

Status unknown Last updated 5 February 2020

What this trial tests

trial testing no intervention in Acute Myocardial Infarction in 1,930 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
1 December 2022

31 December 2023

Quick facts

Lead sponsor	Turkish Society of Cardiology
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,930
Start date	1 November 2018
Primary completion	1 December 2022
Estimated completion	31 December 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

no intervention

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Turkish Society of Cardiology

Who can join

18 and older, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no up-to-date information regarding presentation, management and clinical course of patients with acute myocardial infarction (MI) in Turkey. TURKMI registry is designed to provide insight to the characteristics, management from symptom onset to the hospital discharge and outcome of patients with acute MI in Turkey.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.
Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, et al · · 2020 · cited 68× · PMID 33122486 · DOI 10.14744/anatoljcardiol.2020.98607
Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry.
Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, et al · · 2021 · cited 14× · PMID 33960304 · DOI 10.5152/anatoljcardiol.2021.39797
Rationale and design of the Turkish acute myocardial infarction registry: The TURKMI Study.
Erol MK, Kayıkçıoğlu M, Kılıçkap M. · · 2020 · cited 11× · PMID 32120363 · DOI 10.14744/anatoljcardiol.2019.57522
Clinical Presentation and Outcomes in Real-Life Management of Elderly Patients Aged ≥75 Years Presenting with Acute Myocardial Infarction.
Özdoğan Ö, Kayıkçıoğlu M, Kılıçkap M, Ekmekçi C, et al · · 2022 · PMID 35435840 · DOI 10.5152/anatoljcardiol.2021.1096
Treatment Delays and In-Hospital Outcomes in Acute Myocardial Infarction During the COVID-19 Pandemic: A Nationwide Study
Erol MK, Kayikcioglu M, Kilickap M, Guler A, et al · · 2020 · DOI 10.2139/ssrn.3638442

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other Turkish Society of Cardiology trials

Trials by the same sponsor.

NCT04915235 — Prevalence and Prognosis of Cardiac Amiloidosis in Turkey · unknown
NCT04069598 — Statin Intolerance in Patients With Myocardial Infarction · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04241770 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Turkish Society of Cardiology
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing